Developer of a sequencing platform intended to drive the development of cell and gene therapies that are safer by design. The company's platform combines novel sequencing techniques, bioinformatics analysis, and artificial intelligence, providing healthcare professionals with a data-driven approach to safely introduce the next generation of innovative medicines, including cells and gene therapies.
Venture Capital
Current
Europe
Financing round - Series A
Life Science Tools
2023
Status
Creation Date
Number of Employees
Investment Date
Fund Name